- Ownership
-
Epizyme, Inc. Insider Trading
* In original currency USD
Loading Data
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Friday, August 12th, 2022 | Giordano Michael F | director: | 0 | D-Return | D | 8,994 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | GOLDFISCHER CARL | director | 8,994 | D-Return | D | 13,060 | 1.45 USD | 18,937 USD |
| Friday, August 12th, 2022 | GOLDFISCHER CARL | director: | 0 | D-Return | D | 8,994 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | GOLDFISCHER CARL | director | 0 | D-Return | D | 3,380,951 | 1.45 USD | 4,902,379 USD |
| Friday, August 12th, 2022 | Conroy Kevin T | director: | 8,994 | D-Return | D | 53,324 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | Richon Victoria | director: | 0 | D-Return | D | 8,994 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | MOTT DAVID M | director | 8,994 | U-Tender | D | 215,494 | 1.45 USD | 312,466 USD |
| Friday, August 12th, 2022 | MOTT DAVID M | director: | 8,994 | U-Tender | D | 215,494 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | MOTT DAVID M | director | 0 | U-Tender | D | 106,959 | 1.45 USD | 155,091 USD |
| Friday, August 12th, 2022 | MOTT DAVID M | director: | 0 | D-Return | D | 8,994 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | BEVERIDGE, ROY A | director | 25,696 | D-Return | D | 20,341 | 1.45 USD | 29,495 USD |
| Friday, August 12th, 2022 | BEVERIDGE, ROY A | director: | 0 | D-Return | D | 25,696 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | Agarwal Shefali | other: See Remarks | 107,292 | D-Return | D | 179,247 | 1.45 USD | 259,908 USD |
| Friday, August 12th, 2022 | Agarwal Shefali | director: | 0 | D-Return | D | 107,292 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | Korn Jerald | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Friday, August 12th, 2022 | Royalty Pharma Investments 2019 ICAV | director: | 0 | D-Return | D | 8,994 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | Royalty Pharma Investments 2019 ICAV | director: | 0 | U-Tender | D | 31,933,334 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | Beaulieu Joseph | officer: See Remarks | 21,895 | D-Return | D | 30,181 | 1.45 USD | 43,762 USD |
| Friday, August 12th, 2022 | Beaulieu Joseph | officer: See Remarks | 21,895 | D-Return | D | 30,181 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | Beaulieu Joseph | officer: See Remarks | 0 | D-Return | D | 21,895 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | BATE KENNETH | director: | 8,994 | D-Return | D | 8,060 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | BATE KENNETH | director | 8,994 | D-Return | D | 8,060 | 1.45 USD | 11,687 USD |
| Friday, August 12th, 2022 | BATE KENNETH | director | 0 | D-Return | D | 8,994 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | Kutok Jeffery | officer: Chief Scientific Officer | 81,021 | D-Return | D | 39,046 | 1.45 USD | 56,617 USD |
| Friday, August 12th, 2022 | Kutok Jeffery | officer: Chief Scientific Officer | 0 | D-Return | D | 81,021 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | Stuckley Carol | director: | 0 | D-Return | D | 25,696 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | Bogle Grant C. | director, officer: President and CEO | 175,000 | D-Return | D | 84,170 | 1.45 USD | 122,047 USD |
| Friday, August 12th, 2022 | Bogle Grant C. | officer: President and CEO | 175,000 | D-Return | D | 84,170 | 0.00 USD | 0 USD |
| Friday, August 12th, 2022 | Bogle Grant C. | director, officer: President and CEO | 0 | D-Return | D | 175,000 | 0.00 USD | 0 USD |
| Tuesday, August 9th, 2022 | Bogle Grant C. | director, officer: See Remarks | 983,060 | M-Exempt | A | 800,000 | 1.39 USD | 1,112,000 USD |
| Tuesday, August 9th, 2022 | Bogle Grant C. | director, officer: See Remarks | 654,253 | M-Exempt | A | 417,500 | 1.41 USD | 588,675 USD |
| Tuesday, August 9th, 2022 | Bogle Grant C. | officer: See Remarks | 259,170 | F-InKind | D | 395,083 | 1.41 USD | 557,067 USD |
| Tuesday, August 9th, 2022 | Bogle Grant C. | director, officer: See Remarks | 236,753 | F-InKind | D | 746,307 | 1.39 USD | 1,037,367 USD |
| Tuesday, August 9th, 2022 | Bogle Grant C. | officer: See Remarks | 0 | M-Exempt | D | 417,500 | 0.00 USD | 0 USD |
| Tuesday, August 9th, 2022 | Bogle Grant C. | director, officer: See Remarks | 0 | M-Exempt | D | 800,000 | 1.39 USD | 1,112,000 USD |
| Tuesday, August 9th, 2022 | Bogle Grant C. | director, officer: See Remarks | 0 | M-Exempt | D | 417,500 | 1.41 USD | 588,675 USD |
| Tuesday, August 9th, 2022 | Agarwal Shefali | other: See Remarks | 658,716 | M-Exempt | A | 400,000 | 1.39 USD | 556,000 USD |
| Tuesday, August 9th, 2022 | Agarwal Shefali | other: See Remarks | 443,473 | M-Exempt | D | 56,527 | 1.39 USD | 78,573 USD |
| Tuesday, August 9th, 2022 | Agarwal Shefali | other: See Remarks | 400,000 | M-Exempt | D | 43,473 | 1.39 USD | 60,428 USD |
| Tuesday, August 9th, 2022 | Agarwal Shefali | director: | 285,562 | F-InKind | D | 373,154 | 1.39 USD | 518,684 USD |
| Tuesday, August 9th, 2022 | Agarwal Shefali | other: See Remarks | 258,716 | M-Exempt | A | 43,473 | 1.39 USD | 60,428 USD |
| Tuesday, August 9th, 2022 | Agarwal Shefali | other: See Remarks | 215,243 | M-Exempt | A | 56,527 | 1.39 USD | 78,573 USD |
| Tuesday, August 9th, 2022 | Agarwal Shefali | director: | 0 | M-Exempt | D | 400,000 | 0.00 USD | 0 USD |
| Tuesday, August 9th, 2022 | Agarwal Shefali | other: See Remarks | 0 | M-Exempt | D | 400,000 | 1.39 USD | 556,000 USD |
| Tuesday, August 9th, 2022 | Beaulieu Joseph | officer: See Remarks | 330,963 | M-Exempt | A | 300,000 | 1.39 USD | 417,000 USD |
| Tuesday, August 9th, 2022 | Beaulieu Joseph | officer: See Remarks | 51,099 | F-InKind | D | 279,864 | 1.39 USD | 389,011 USD |
| Tuesday, August 9th, 2022 | Beaulieu Joseph | officer: See Remarks | 0 | M-Exempt | D | 300,000 | 0.00 USD | 0 USD |
| Tuesday, August 9th, 2022 | Beaulieu Joseph | officer: See Remarks | 0 | M-Exempt | D | 300,000 | 1.39 USD | 417,000 USD |
| Tuesday, August 9th, 2022 | Kutok Jeffery | officer: Chief Scientific Officer | 474,563 | M-Exempt | A | 380,000 | 1.39 USD | 528,200 USD |
| Tuesday, August 9th, 2022 | Kutok Jeffery | officer: Chief Scientific Officer | 120,067 | F-InKind | D | 354,496 | 1.39 USD | 492,749 USD |
| Tuesday, August 9th, 2022 | Kutok Jeffery | officer: Chief Scientific Officer | 0 | M-Exempt | D | 380,000 | 1.39 USD | 528,200 USD |
| Thursday, June 30th, 2022 | MOTT DAVID M | director: | 224,488 | A-Award | A | 16,156 | 1.47 USD | 23,749 USD |
| Thursday, June 30th, 2022 | BEVERIDGE, ROY A | director: | 46,037 | A-Award | A | 8,928 | 1.47 USD | 13,124 USD |
| Thursday, June 30th, 2022 | Conroy Kevin T | director: | 62,318 | A-Award | A | 10,204 | 1.47 USD | 15,000 USD |
| Tuesday, May 17th, 2022 | Royalty Pharma Investments 2019 ICAV | director: | 41,006 | A-Award | A | 41,006 | 0.56 USD | 22,963 USD |
| Tuesday, May 17th, 2022 | BATE KENNETH | director | 41,006 | A-Award | A | 41,006 | 0.56 USD | 22,963 USD |
| Tuesday, May 17th, 2022 | BATE KENNETH | director: | 41,006 | A-Award | A | 41,006 | 0.00 USD | 0 USD |
| Tuesday, May 17th, 2022 | BATE KENNETH | director | 17,054 | A-Award | A | 8,994 | 0.00 USD | 0 USD |
| Tuesday, May 17th, 2022 | Richon Victoria | director: | 22,608 | A-Award | A | 8,994 | 0.00 USD | 0 USD |
| Tuesday, May 17th, 2022 | Stuckley Carol | director: | 25,696 | A-Award | A | 8,994 | 0.00 USD | 0 USD |
| Tuesday, May 17th, 2022 | Giordano Michael F | director: | 41,006 | A-Award | A | 41,006 | 0.00 USD | 0 USD |
| Tuesday, May 17th, 2022 | MOTT DAVID M | director: | 208,332 | A-Award | A | 8,994 | 0.00 USD | 0 USD |
| Tuesday, May 17th, 2022 | MOTT DAVID M | director | 41,006 | A-Award | A | 41,006 | 0.56 USD | 22,963 USD |
| Tuesday, May 17th, 2022 | Conroy Kevin T | director: | 52,114 | A-Award | A | 8,994 | 0.00 USD | 0 USD |
| Tuesday, May 17th, 2022 | GOLDFISCHER CARL | director | 41,006 | A-Award | A | 41,006 | 0.56 USD | 22,963 USD |
| Tuesday, May 17th, 2022 | GOLDFISCHER CARL | director: | 22,054 | A-Award | A | 8,994 | 0.00 USD | 0 USD |
| Tuesday, May 17th, 2022 | BEVERIDGE, ROY A | director | 41,006 | A-Award | A | 41,006 | 0.56 USD | 22,963 USD |
| Tuesday, May 17th, 2022 | BEVERIDGE, ROY A | director: | 37,109 | A-Award | A | 8,994 | 0.00 USD | 0 USD |
| Monday, April 11th, 2022 | Kutok Jeffery | officer: Chief Scientific Officer | 94,563 | S-Sale | D | 2,741 | 0.90 USD | 2,467 USD |
| Friday, April 1st, 2022 | Korn Jerald | officer: Chief Operating Officer | 800,000 | A-Award | A | 800,000 | 0.00 USD | 0 USD |
| Friday, April 1st, 2022 | Korn Jerald | officer: Chief Operating Officer | 800,000 | A-Award | A | 800,000 | 1.14 USD | 912,000 USD |
| Thursday, March 31st, 2022 | BEVERIDGE, ROY A | director: | 28,115 | A-Award | A | 11,413 | 1.15 USD | 13,125 USD |
| Thursday, March 31st, 2022 | MOTT DAVID M | director: | 199,338 | A-Award | A | 20,653 | 1.15 USD | 23,751 USD |
| Thursday, March 31st, 2022 | Conroy Kevin T | director: | 43,120 | A-Award | A | 13,043 | 1.15 USD | 14,999 USD |
| Thursday, March 17th, 2022 | Bogle Grant C. | officer: See Remarks | 800,000 | A-Award | A | 800,000 | 0.00 USD | 0 USD |
| Thursday, March 17th, 2022 | Bogle Grant C. | director, officer: See Remarks | 800,000 | A-Award | A | 800,000 | 1.39 USD | 1,112,000 USD |
| Thursday, March 17th, 2022 | Beaulieu Joseph | officer: See Remarks | 300,000 | A-Award | A | 300,000 | 0.00 USD | 0 USD |
| Thursday, March 17th, 2022 | Beaulieu Joseph | officer: See Remarks | 300,000 | A-Award | A | 300,000 | 1.39 USD | 417,000 USD |
| Monday, February 28th, 2022 | Beaulieu Joseph | officer: See Remarks | 30,963 | A-Award | A | 2,331 | 1.27 USD | 2,952 USD |
| Thursday, March 17th, 2022 | Kutok Jeffery | officer: Chief Scientific Officer | 380,000 | A-Award | A | 380,000 | 0.00 USD | 0 USD |
| Thursday, March 17th, 2022 | Kutok Jeffery | officer: Chief Scientific Officer | 380,000 | A-Award | A | 380,000 | 1.39 USD | 528,200 USD |
| Thursday, March 17th, 2022 | Agarwal Shefali | officer: See Remarks | 500,000 | A-Award | A | 500,000 | 1.39 USD | 695,000 USD |
| Thursday, March 17th, 2022 | Agarwal Shefali | officer: See Remarks | 500,000 | A-Award | A | 500,000 | 0.00 USD | 0 USD |
| Monday, February 28th, 2022 | Agarwal Shefali | officer: See Remarks | 158,716 | A-Award | A | 2,331 | 1.27 USD | 2,952 USD |
| Monday, March 21st, 2022 | Korn Jerald | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Monday, February 7th, 2022 | Beaulieu Joseph | officer: Corporate Controller | 28,632 | S-Sale | D | 222 | 1.50 USD | 333 USD |
| Monday, February 7th, 2022 | Agarwal Shefali | officer: See Remarks | 156,385 | S-Sale | D | 1,058 | 1.50 USD | 1,587 USD |
| Monday, January 31st, 2022 | Royalty Pharma Investments 2019 ICAV | director, 10 percent owner: | 22,666,667 | D | 0 | 0.00 USD | 0 USD | |
| Wednesday, February 2nd, 2022 | Agarwal Shefali | officer: See Remarks | 157,443 | S-Sale | D | 2,639 | 1.37 USD | 3,615 USD |
| Wednesday, February 2nd, 2022 | Bogle Grant C. | director, officer: See Remarks | 417,500 | A-Award | A | 417,500 | 1.41 USD | 588,675 USD |
| Wednesday, February 2nd, 2022 | Bogle Grant C. | director, officer: See Remarks | 183,060 | A-Award | A | 87,500 | 0.00 USD | 0 USD |
| Wednesday, February 2nd, 2022 | Kutok Jeffery | officer: Chief Scientific Officer | 97,304 | S-Sale | D | 2,556 | 1.37 USD | 3,502 USD |
| Wednesday, February 2nd, 2022 | Beaulieu Joseph | officer: Corporate Controller | 28,854 | S-Sale | D | 687 | 1.37 USD | 941 USD |
| Monday, January 31st, 2022 | Legorreta Pablo G. | director, 10 percent owner: | 31,833,334 | P-Purchase | A | 22,666,667 | 1.50 USD | 34,000,001 USD |
| Wednesday, January 26th, 2022 | Agarwal Shefali | officer: See Remarks | 160,082 | S-Sale | D | 2,922 | 2.02 USD | 5,902 USD |
| Friday, December 31st, 2021 | MOTT DAVID M | director | 178,685 | A-Award | A | 9,500 | 2.50 USD | 23,750 USD |
| Friday, December 31st, 2021 | Conroy Kevin T | director | 30,077 | A-Award | A | 6,000 | 2.50 USD | 15,000 USD |
| Monday, December 6th, 2021 | Agarwal Shefali | officer: See Remarks | 163,004 | S-Sale | D | 1,780 | 2.93 USD | 5,215 USD |
| Tuesday, November 16th, 2021 | BEVERIDGE, ROY A | director | 83,298 | A-Award | A | 83,298 | 4.27 USD | 355,683 USD |
| Tuesday, November 16th, 2021 | BEVERIDGE, ROY A | director | 16,702 | A-Award | A | 16,702 | 0.00 USD | 0 USD |
